Background
Methods
Study sample size calculation
Exclusion and inclusion criteria
Data collection
Rank 1 | Narrow spectrum, including first-generation and second –generation cephalosporins, amoxicillin, co-trimoxazole, metronidazole, and oral vancomycin; |
Rank 2 | Broad spectrum, including flouroquinolones, macrolides, third-generation cephalosporins, co-amoxiclav, clindamycin; |
Rank 3 | Extended spectrum, including antipseudomonal penicillins, antipseudomonal carbapenems and intravenous vancomycin; |
Rank 4 | Restricted, including colistin, tigecycline, linezolid, and daptomycin |
-
Was the indication documented on the electronic chart or the medical notes?
-
Did the indication have a matching recommendation in the policy?
-
If there was no recommendation in the policy, was there any infection team input?
Data analysis
Results
Descriptive statistics
Diagnostic Information | Total 326 n (%) | Medicine 162 n (%) | Surgery 164 n (%) |
---|---|---|---|
White Cell Count | |||
Normal (4.2–11.2 × 109/L) | 128 (39.3) | 76 (47.0) | 52 (31.7) |
Abnormal | 197 (60.4) | 86 (53.0) | 111 (68.1) |
No Data | 1 (0.3) | 0 | 1 (0.6) |
Body Temperature | |||
Normal (36.5–37.5 °C) | 168 (51.5) | 70 (43.2) | 98 (60.0) |
Abnormal | 157 (48.2) | 91 (56.2) | 66 (40.0) |
No Data | 1 (0.3) | 1 (0.6) | 0 |
Body temperature and White Cell Count | |||
Normal | 64 (19.4) | 32 (19.4) | 32 (19.4) |
Abnormal | 260 (80.0) | 129 (80.0) | 131(80.0) |
No Data | 2 (0.6) | 1 (0.6) | 1 (0.6) |
C-reactive Protein | |||
Normal (< 6 mg/L) | 17 (5.2) | 11 (7.0) | 6 (3.7) |
Abnormal (> 6 mg/L) | 308 (94.5) | 151 (93.0) | 157 (95.7) |
No Data | 1 (0.3) | 0 | 1 (0.6) |
Chest X-ray at start of antibiotic | |||
Yes | 154 (47.0) | 90 (55.6) | 64 (39.0) |
No | 172 (53.0) | 72 (44.4) | 100 (61.0) |
Sign of infection on chest X-ray | |||
Yes | 53 (16.0) | 36 (22.0) | 17 (10.0) |
No | 101 (31.0) | 54 (33.3) | 47 (29.0) |
No imaging | 172 (53.0) | 72 (44.4) | 100 (61.0) |
Microbiological culture collected before antibiotic initiation | |||
Yes | 90 (27.6) | 42 (26.0) | 48 (29.0) |
No | 236 (72.4) | 120 (74.0) | 116 (71.0) |
The result of microbiological culture collected before antibiotic initiation | |||
No growth (negative culture) | 44 (13.5) | 19 (11.7) | 25 (15.0) |
Pathogen grown (positive culture) | 46 (14.1) | 23 (14.2) | 23 (14.0) |
No Culture | 236 (72.4) | 120 (74.1) | 116 (71.0) |
Indication for antibiotic therapy | Total 326 n (%) | Medicine 162 n (%) | Surgery 164 n (%) |
---|---|---|---|
Respiratory | 104 (31.90) | 90 (55.56) | 14 (8.54) |
Urinary tract | 39 (11.96) | 29 (17.90) | 10 (6.10) |
Intraperitoneal/ Gastrointestinal | 48 (14.72) | 4 (2.47) | 44 (26.83) |
Skin and soft tissue | 16 (4.91) | 8 (4.94) | 8 (4.88) |
Sepsis | 19 (5.83) | 5 (3.09) | 14 (8.54) |
Biliary | 39 (11.96) | 0 | 39 (23.78) |
Other* | 61 (18.71) | 26 (16.05) | 35 (21.34) |
Variable | Measure | Medicine N = 162 | Surgery N = 164 | P value* |
---|---|---|---|---|
Gender - Male | n (%) | 76 (47) | 84 (51) | 0.441 |
Age at admission | Mean (SD) | 70 (18) | 55 (22) | – |
Median (Interquartile range) | 74 (27–93) | 55 (18–92) | < 0.001 | |
Range (Minimum – Maximum) | 21–104 | 18–95 | – | |
Length of Stay | Mean (SD) | 11 (15) | 16 (24) | 0.0553 |
Median (Interquartile range) | 7 (1–76) | 5 (2–106) | < 0.001 | |
Range (Minimum – Maximum) | 1–95 | 24–160 | – | |
Charlson comorbidity index (age adjusted) | n (%) | |||
Low (score of 0–2) | 30 (19) | 89 (54) | < 0.001 | |
Moderate (score of 3–4) | 39 (24) | 23 (14) | ||
Severe (score of ≥5) | 93 (57) | 52 (32) | ||
30 day readmission | n (%) | 43 (27) | 29 (18) | < 0.001 |
Mortality in admission episode | n (%) | 10 (6) | 10 (6) | 0.977 |
Medicine 162 n (%) | Surgery 164 n (%) | p value * | |
---|---|---|---|
Total number of courses of antibiotics | 395 | 461 | – |
Route of antibiotics (as a total of all courses) | |||
Intravenous | 200 (51) | 395 (86) | < 0.001 |
Oral | 195(49) | 66 (14) | |
Number of antibiotics during spell | |||
1 | 36 (22.22) | 12 (7.32) | 0.001 |
2 | 52 (32.10) | 68 (41.46) | |
≥ 3 | 74 (45.68) | 84 (51.22) | |
Antibiotic exposure days | |||
1–3 days | 65 (40) | 56 (34) | 0.134 |
4–7 days | 55 (34) | 52 (32) | |
7–14 days | 28 (17) | 33 (20) | |
≥ 15 | 14 (9) | 23 (14) | |
Cumulative antibiotic days | |||
1–7 days | 94 (58) | 70 (43) | 0.016 |
8–14 days | 46 (28) | 44 (27) | |
≥ 15 | 22 (14) | 50 (30) | |
Antibiotic rank | |||
Narrow | 11(6.79) | 6 (3.66) | 0.507 |
Broad | 98 (60.49) | 95 (57.93) | |
Extended | 47 (29.00) | 56 (34.15) | |
Restricted | 6 (3.70) | 7 (4.27) | |
Change to initial antibiotic course | |||
No change/discontinued | 76 (46.91) | 90 (54.88) | 0.0037 |
Antibiotic escalated | 31 (19.14) | 49 (29.88) | |
Antibiotic de-escalated | 55(33.95) | 25 (15.24) | |
Antibiotic compliant to local policy | |||
Yes | 131 (80.86) | 108 (65.85) | < 0.001 |
No | 30 (18.52) | 35 (21.34) | |
Unclear | 1 (0.62) | 21 (12.80) | |
Antibiotic compliant to local policy (‘unclear’ treated as missing) | |||
Yes | 131 (81.37) | 108 (75.52) | 0.215 |
No | 30 (18.63) | 35 (24.48) | |
Antibiotic prescribed on discharge | |||
Yes | 80 (49) | 73 (45) | 0.677 |
No | 67 (41) | 74 (45) | |
No data/Patient died | 15 (9) | 17 (10) |
OR | 95% CI | Crude P | Adjusted ORa | 95% CI | Adjusted P value | |
---|---|---|---|---|---|---|
Specialty | ||||||
Medicine | 1 | 1 | ||||
Surgery | 1.801 | 1.076–3.013 | 0.024 | 1.942 | 1.067–3.534 | 0.030 |
Comorbidity score | ||||||
Low | 1 | 1 | ||||
Mod | 1.164 | 0.629 – | 0.629 | 0.845 | 0.402–1.773 | 0.655 |
Severe | 1.380 | 2.151 0.741–2.570 | 0.310 | 1.123 | 0.541–2.354 | 0.747 |
Culture and sensitivity | ||||||
Negative | 1 | 1 | ||||
Positive | 0.569 | 0.236 – | 0.209 | 0.583 | 0.218–1.559 | 0.282 |
No culture | 0.378 | 1.371 0.192–0.746 | 0.005 | 0.470 | 0.219–1.009 | 0.053 |
Los | ||||||
1–7 | 1 | 1 | ||||
8–14 | 2.027 | 0.998 – | 0.051 | 2.012 | 0.962–4.215 | 0.064 |
≥ 15 | 5.758 | 4.117 3.137–10.567 | < 0.001 | 5.138 | 2.66–9.910 | < 0.001 |
Sign of infection on chest X-ray | ||||||
No | 1 | 1 | ||||
Yes | 1.145 | 0.563 – | 0.709 | 1.405 | 0.635–3.109 | 0.402 |
No chest X-ray | 0.486 | 2.323 0.273–0.863 | 0.014 | 0.610 | 0.328–1.173 | 0.142 |